You are here > Achievements  > 2009 - 2010


Closing in October 2009 of a 5.3 million euros A-round of funding complemented by more than 4 million euros of grants and loans from the Walloon Region.

Promethera Biosciences has been founded in February 2009. The company raises 5.3 million euros through series A capital round end October 2009 complemented by 4M€ of loans and grants from the Walloon region. Vesalius Biocapital is the lead investor of the company and is committed to support the company in Round-B.


PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
B-1435 Mont-Saint-Guibert
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01

News and Public release

CEO John Tchelingerian to Discuss Strategic Collobarations and Partnering Strategies in Cell Therapy at ARM’s Advanced Therapies Summit
Collaboration to Drive Development and Commercialization of Promethera’s Cell-based Liver-Focused Therapeutics Portfolio in Korea